SCHEDULE 13G/A
Statement of Beneficial Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0000905148-26-004951
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 6,002,989 | 5.7% |
| Viking Global Opportunities Parent GP LLC | 6,002,989 | 5.7% |
| HALVORSEN OLE ANDREAS | 6,002,989 | 5.7% |
| Shabet Rose Sharon | 6,002,989 | 5.7% |
| Viking Global Opportunities GP LLC | 3,766,111 | 3.5% |
| Viking Global Opportunities Portfolio GP LLC | 3,766,111 | 3.5% |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 3,766,111 | 3.5% |
| Viking Global Opportunities Drawdown GP LLC | 2,236,878 | 2.1% |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2,236,878 | 2.1% |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2,236,878 | 2.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…